Special Counsel Eric Berg was quoted in a Compliance Week article, “As SEC Targets EB-5 Fraud, the Visa Program Could Raise Money Laundering Risks,” on March 29, 2016. The article discussed the increasing use of the Employment-Based Fifth (EB-5) Preference program, which encourages capital investment in the United States by foreign investors in exchange for “green cards.” The program has come under scrutiny in regards to money laundering and the Securities and Exchange Commission (SEC) has started targeting the program.
Berg discussed how financial institutions have yet to be targeted, even after the SEC has begun working with the Financial Industry Regulatory Authority. He was quoted saying, “The government is paying more attention to the corrupt acquisition of wealth overseas. The risk to financial institutions is determining how the wealth was obtained and trying, to the best of their ability, not to deal with tainted funds. When foreign investors bring money into this country, it would probably behoove you to do more than the standard due diligence you would for opening a checking and savings account.”
Berg discussed how financial institutions have yet to be targeted, even after the SEC has begun working with the Financial Industry Regulatory Authority. He was quoted saying, “The government is paying more attention to the corrupt acquisition of wealth overseas. The risk to financial institutions is determining how the wealth was obtained and trying, to the best of their ability, not to deal with tainted funds. When foreign investors bring money into this country, it would probably behoove you to do more than the standard due diligence you would for opening a checking and savings account.”
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.
April 1, 2026
In the News
Foley Featured on Top 10 Sales of 2025 List by Golf Inc.
Foley & Lardner LLP advised on two transactions named among Golf Inc.’s Top 10 Sales of 2025.